INMD
$13.65
InMode Ltd.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe,...
Recent News
How InMode’s New 10% Share Buyback Plan Will Impact InMode (INMD) Investors
On March 13, 2026, InMode Ltd. announced that its Board of Directors approved a share repurchase program for up to 6,380,000 shares, or 10% of its outstanding stock, to be funded with existing cash. This fresh authorization, coming after the company previously spent about US$127.4 million on buybacks in 2025, highlights management’s ongoing emphasis on returning capital to shareholders alongside other capital allocation options. With this new buyback authorization now in place, we’ll explore...
Sector Update: Health Care Stocks Advance Friday Afternoon
Health care stocks rose Friday afternoon, with the NYSE Health Care Index increasing 0.3% and the St
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Oil Prices Ease From Recent Surge
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad
InMode Ltd. Q4 2025 Earnings Call Summary
Moby summary of InMode Ltd.'s Q4 2025 earnings call
InMode Ltd (INMD) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
Despite a year-over-year revenue decline, InMode Ltd (INMD) sees promising growth in international sales and prepares for new product launches in 2026.